MDxHealth SA
MDXH
$0.69
-$0.02-3.01%
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 27.21M | 29.55M | 26.61M | 24.29M | 23.32M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.21M | 29.55M | 26.61M | 24.29M | 23.32M |
| Cost of Revenue | 9.32M | 10.86M | 9.04M | 8.79M | 9.04M |
| Gross Profit | 17.89M | 18.69M | 17.57M | 15.50M | 14.28M |
| SG&A Expenses | 19.60M | 19.63M | 16.16M | 15.66M | 16.35M |
| Depreciation & Amortization | 1.26M | 1.25M | 1.32M | 1.32M | 1.33M |
| Other Operating Expenses | 139.00K | -206.00K | -561.00K | 608.00K | -11.00K |
| Total Operating Expenses | 32.31M | 34.81M | 28.52M | 28.88M | 29.41M |
| Operating Income | -5.10M | -5.26M | -1.92M | -4.59M | -6.09M |
| Income Before Tax | -9.48M | -10.50M | -7.79M | -9.07M | -10.85M |
| Income Tax Expenses | -- | -1.57M | -416.00K | 137.00K | 344.00K |
| Earnings from Continuing Operations | -9.48M | -8.93M | -7.37M | -9.21M | -11.19M |
| Earnings from Discontinued Operations | -2.05M | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.53M | -8.93M | -7.37M | -9.21M | -11.19M |
| EBIT | -5.10M | -5.26M | -1.92M | -4.59M | -6.09M |
| EBITDA | -2.71M | -2.82M | -216.00K | -2.34M | -3.94M |
| EPS Basic | -0.22 | -0.17 | -0.14 | -0.19 | -0.40 |
| Normalized Basic EPS | -0.11 | -0.01 | -0.02 | -- | -- |
| EPS Diluted | -0.22 | -0.17 | -0.14 | -0.19 | -0.40 |
| Normalized Diluted EPS | -0.11 | -0.01 | -0.02 | -- | -- |
| Average Basic Shares Outstanding | 52.42M | 52.52M | 52.02M | 48.47M | 27.97M |
| Average Diluted Shares Outstanding | 52.42M | 52.52M | 52.02M | 48.47M | 27.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |